Backed by the trusted Tata Group, Tata 1mg has demonstrated strong financial growth, with operational revenue rising 21% to ₹1,968 crore in FY 2023–24 and net losses shrinking by an impressive 75%. This solid performance reflects the brand’s growing market dominance and operational efficiency. As India’s e-pharmacy and digital healthcare sectors expand rapidly, a Tata 1mg franchise pr... https://launchlify.com/tata-1mg-franchise-cost/